Regulatory Pathways Supporting Expedited Drug Development and Approval in ICH Member Countries

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2168-4804

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Regulatory Pathways Supporting Expedited Drug Development and Approval in ICH Member Countries ; day:3 ; month:12 ; year:2022 ; pages:1-31
Therapeutic innovation & regulatory science ; (3.12.2022), 1-31

Creator: Franco, Pedro
Jain, Ritesh
Rosenkrands-Lange, Elizabeth
Hey, Claudia
Koban, Marén U.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s43441-022-00480-3

URN: urn:nbn:de:101:1-2023021421142067666664

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Franco, Pedro
Jain, Ritesh
Rosenkrands-Lange, Elizabeth
Hey, Claudia
Koban, Marén U.
SpringerLink (Online service)

Other Objects (12)

Approval voting

A normalized quality of life approach for regulatory approval of medical devices

Type approval procedures for telecommunications terminal equipment in OECD member countries : information computer communications policy

Clinical pharmacology strategies in supporting drug development and approval of antibody–drug conjugates in oncology

Verschiedenes

On approval (DT)

Sparsentan: First Approval

Eplontersen: First Approval

Zilucoplan: First Approval

Approval-based shortlisting

Zavegepant: First Approval

Spesolimab: First Approval

Lonafarnib: First Approval

Approval voting

A normalized quality of life approach for regulatory approval of medical devices

Type approval procedures for telecommunications terminal equipment in OECD member countries : information computer communications policy

Clinical pharmacology strategies in supporting drug development and approval of antibody–drug conjugates in oncology

Verschiedenes

On approval (DT)

Sparsentan: First Approval

Eplontersen: First Approval

Zilucoplan: First Approval

Approval-based shortlisting

Zavegepant: First Approval

Spesolimab: First Approval

Lonafarnib: First Approval

Approval voting

A normalized quality of life approach for regulatory approval of medical devices

Type approval procedures for telecommunications terminal equipment in OECD member countries : information computer communications policy

Clinical pharmacology strategies in supporting drug development and approval of antibody–drug conjugates in oncology

Verschiedenes

On approval (DT)

Sparsentan: First Approval

Eplontersen: First Approval

Zilucoplan: First Approval

Approval-based shortlisting

Zavegepant: First Approval

Spesolimab: First Approval

Lonafarnib: First Approval

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Regulatory Pathways Supporting Expedited Drug Development and Approval in ICH Member Countries

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Approval voting

A normalized quality of life approach for regulatory approval of medical devices

Type approval procedures for telecommunications terminal equipment in OECD member countries : information computer communications policy

Clinical pharmacology strategies in supporting drug development and approval of antibody–drug conjugates in oncology

On approval (DT)

Sparsentan: First Approval

Eplontersen: First Approval

Zilucoplan: First Approval

Approval-based shortlisting

Zavegepant: First Approval

Spesolimab: First Approval

Lonafarnib: First Approval

Approval voting

A normalized quality of life approach for regulatory approval of medical devices

Type approval procedures for telecommunications terminal equipment in OECD member countries : information computer communications policy

Clinical pharmacology strategies in supporting drug development and approval of antibody–drug conjugates in oncology

On approval (DT)

Sparsentan: First Approval

Eplontersen: First Approval

Zilucoplan: First Approval

Approval-based shortlisting

Zavegepant: First Approval

Spesolimab: First Approval

Lonafarnib: First Approval

Approval voting

A normalized quality of life approach for regulatory approval of medical devices

Type approval procedures for telecommunications terminal equipment in OECD member countries : information computer communications policy

Clinical pharmacology strategies in supporting drug development and approval of antibody–drug conjugates in oncology

On approval (DT)

Sparsentan: First Approval

Eplontersen: First Approval

Zilucoplan: First Approval

Approval-based shortlisting

Zavegepant: First Approval

Spesolimab: First Approval

Lonafarnib: First Approval

Related objects

Reset password